Nystatin and Tresiba drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Nystatin and Tresiba. Common interactions include vomiting among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people who take Nystatin and Tresiba have. It is created by eHealthMe based on reports of 54 people who take Nystatin and Tresiba from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
54 people who take Nystatin and Tresiba together, and have interactions are studied.
What is Nystatin?
Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 26,492 Nystatin users for its effectiveness, alternative drugs and more.
What is Tresiba?
Tresiba has active ingredients of insulin degludec. It is often used in type 1 diabetes. eHealthMe is studying from 13,860 Tresiba users for its effectiveness, alternative drugs and more.
Number of Nystatin and Tresiba reports submitted per year:
Common Nystatin and Tresiba drug interactions by gender *:
- Abscess limb
- Adverse drug reaction
- Arthropod bite
- Back disorder
- Blood glucose decreased
- Blood glucose fluctuation
- Renal failure
- Tooth loss
- Bone loss
- Hyperparathyroidism secondary
- Abnormal dreams
Common Nystatin and Tresiba drug interactions by age *:
- Chronic kidney disease
- Renal failure
- Suicidal ideation
- Suicide attempt
- Tooth loss
- Arthropod bite
- Blood glucose increased
- Diabetic foot
- Glycosylated haemoglobin increased
- Vaginal haemorrhage
- Urinary tract infection
- Gingival bleeding
- Gingival erosion
- Impaired healing
- Joint swelling
- Limb injury
- Loose tooth
Common conditions people have *:
- High Blood Cholesterol: 12 people, 22.22%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 20.37%
- Pain: 11 people, 20.37%
- Diabetes: 10 people, 18.52%
- Anaemia (lack of blood): 9 people, 16.67%
- Depression: 7 people, 12.96%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 12.96%
- High Blood Pressure: 7 people, 12.96%
- Type 2 Diabetes: 6 people, 11.11%
- Hiv Infection: 6 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Nystatin and Tresiba?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Nystatin and Tresiba:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Nystatin interactions:
Browse all interactions between Nystatin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Tresiba interactions:
Browse all interactions between Tresiba and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on nystatin and insulin degludec (the active ingredients of Nystatin and Tresiba, respectively), and Nystatin and Tresiba (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.